ESG's Cardiometabolic Benefits Last 5 Years
Bariatric surgery's benefits have been well described, but endoscopic sleeve gastroplasty is relatively new, so its outcomes haven't been as well described.
Stay updated with breaking news from Phenomix Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bariatric surgery's benefits have been well described, but endoscopic sleeve gastroplasty is relatively new, so its outcomes haven't been as well described.
/PRNewswire/ -- Phenomix Sciences (Phenomix), a precision obesity biotechnology company, announces today the launch of its biobanking registry and outcomes...
Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test What You Should Know: – Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes. – The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to prescribe more precise anti-obesity treat...
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices What You Should Know: – Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research. – SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely ap...
Apr 1, 2021 12:02pm Phenomix Sciences' blood-based test uses phenotype-driven multi-omics technology to predict responses to obesity interventions the Food and Drug Administration has approved. (vadimguzhva/GettyImages) The American Medical Association innovation subsidiary Health2047 has spun off a company that uses personalized medicine to fight obesity. Phenomix Sciences is a phenotype testing company that carries out the AMA’s mission to confront chronic diseases such as obesity. Phenomix uses a blood test called MyPhenome that it has licensed from the Mayo Clinic to allow doctors to pr...